주메뉴 바로가기
서브메뉴 바로가기
본문 바로가기
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15
R&D
Laboratory
Pipeline
Technology
IR
IR Resource
Public Disclosures
Public Disclosures
PR
Notice
News
Materials
Careers
Talents
Welfare
Recruitment
KOR
ENG
Goldmmune
TEL
menu open
VaxcellBio, Inc.
KOR
ENG
menu close
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15 for Companion Animals
R&D
Laboratory
Pipeline
Technology
IR
Public Disclosures
Careers
Talents
Welfare
Recruitment
ⓒ VaxCell Biotherapeutics Co., Ltd.
PR
Notice
News
Materials
News
•
홈
> PR >
News
뉴스(메디컬투데이) - 박셀바이오 기술성평가 통과… 코스닥 상장 가속화
관리자
2019. 12. 23. 15:16
ref.
2823
기사링크:
http://www.mdtoday.co.kr/mdtoday/index.html?no=373417
Prev:
뉴스(약업신문) - 박셀바이오, 전라남도 '2019 고용우수기업' 선정
Next:
뉴스(더벨) - 정광준 박셀바이오 대표 "2022년 스마트 공정 도입"
List